Literature DB >> 32140876

Recreational Use of HIV Antiretroviral Medication and Implications for HIV Pre-exposure Prophylaxis and Treatment.

Caroline Kuo1,2, Danielle Giovenco3, Teresa DeAtley4, Jackie Hoare5, Kristen Underhill6, Millicent Atujuna7, Catherine Mathews8, Dan J Stein5,9, Larry K Brown10, Don Operario4.   

Abstract

Diversion of antiretroviral therapy (ART) for recreational use is concerning for countries with high HIV prevalence. This paper presents reports of recreational use of ART among adolescents from two HIV prevention studies in South Africa: (1) a cross-sectional survey of N = 200 adolescents and (2) a qualitative study of pre-exposure prophylaxis with N = 57 adolescents and N = 25 clinicians. Among adolescents, 3% used and 14% knew someone who used non-prescribed ART for recreational purposes. Administration included smoking (71%), snorting (15%), injecting (15%), ingesting (15%), and inserting (3%). Participants predicted increased crime as recreational use of ART increased. Future studies should investigate prevalence, composition, and diversion of ART from HIV prevention and treatment.

Entities:  

Keywords:  Antiretroviral medication; HIV; Medication diversion; Nyaope; South Africa; Whoonga

Mesh:

Substances:

Year:  2020        PMID: 32140876      PMCID: PMC7725396          DOI: 10.1007/s10461-020-02821-5

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  14 in total

1.  "The Time Has Arrived": Perceptions of Behavioral Adjustments in the Context of Pre-Exposure Prophylaxis Availability Among Adolescents in South Africa.

Authors:  Danielle Giovenco; Caroline Kuo; Kristen Underhill; Jacqueline Hoare; Don Operario
Journal:  AIDS Educ Prev       Date:  2018-12

Review 2.  Adverse Neuropsychiatric Events and Recreational Use of Efavirenz and Other HIV-1 Antiretroviral Drugs.

Authors:  Dhwanil A Dalwadi; Luis Ozuna; Brian H Harvey; Michelle Viljoen; John A Schetz
Journal:  Pharmacol Rev       Date:  2018-07       Impact factor: 25.468

3.  Whoonga: potential recreational use of HIV antiretroviral medication in South Africa.

Authors:  David J Grelotti; Elizabeth F Closson; Jennifer A Smit; Zonke Mabude; Lynn T Matthews; Steven A Safren; David R Bangsberg; Matthew J Mimiaga
Journal:  AIDS Behav       Date:  2014-03

4.  Preliminary evidence of HIV seroconversion among HIV-negative men who have sex with men taking non-prescribed antiretroviral medication for HIV prevention in Miami, Florida, USA.

Authors:  Mance E Buttram; Steven P Kurtz
Journal:  Sex Health       Date:  2017-04       Impact factor: 2.706

5.  Pretreatment antiretroviral exposure from recreational use.

Authors:  David J Grelotti; Elizabeth F Closson; Matthew J Mimiaga
Journal:  Lancet Infect Dis       Date:  2013-01       Impact factor: 25.071

6.  Antiretroviral medication diversion among HIV-positive substance abusers in South Florida.

Authors:  Hilary L Surratt; Steven P Kurtz; Theodore J Cicero; Catherine O'Grady; Maria A Levi-Minzi
Journal:  Am J Public Health       Date:  2013-04-18       Impact factor: 9.308

Review 7.  Antiretroviral medication: an emerging category of prescription drug misuse.

Authors:  Glen P Davis; Hilary L Surratt; Frances R Levin; Carlos Blanco
Journal:  Am J Addict       Date:  2013-09-17

8.  Vulnerable infected populations and street markets for ARVs: Potential implications for PrEP rollout in the USA.

Authors:  Steven P Kurtz; Mance E Buttram; Hilary L Surratt
Journal:  AIDS Care       Date:  2013-09-16

9.  Whoonga and the abuse and diversion of antiretrovirals in Soweto, South Africa.

Authors:  Kathryn Rough; Janan Dietrich; Thandekile Essien; David J Grelotti; David R Bansberg; Glenda Gray; Ingrid T Katz
Journal:  AIDS Behav       Date:  2014-07

10.  Developing family interventions for adolescent HIV prevention in South Africa.

Authors:  Caroline Kuo; Millicent Atujuna; Catherine Mathews; Dan J Stein; Jacqueline Hoare; William Beardslee; Don Operario; Lucie Cluver; Larry K Brown
Journal:  AIDS Care       Date:  2016-02-26
View more
  6 in total

Review 1.  A Systematic Review of Risk Factors and Consequences of Nyaope Usage: The Illicit Street Drug Containing HIV Antiretrovirals.

Authors:  Karan Varshney; Samuel D Browning; Sujit K Debnath; Pavan Shet; Darshan Shet
Journal:  AIDS Behav       Date:  2022-07-27

2.  Antiretroviral Treatment Sharing among Female sex Workers Living with HIV in eThekwini (Durban), South Africa: Drivers and Implications for Treatment Success.

Authors:  Amelia Rock; Carly Comins; Ntambue Mulumba; Katherine Young; Mfezi Mcingana; Vijayanand Guddera; Harry Hausler; Rene Phetlhu; Stefan Baral; Sheree Schwartz
Journal:  J Int Assoc Provid AIDS Care       Date:  2022 Jan-Dec

3.  "PrEP just isn't my priority": Adherence challenges among women who inject drugs participating in a pre-exposure prophylaxis (PrEP) demonstration project in Philadelphia, PA USA.

Authors:  Marisa Felsher; Eliza Ziegler; K Rivet Amico; Adam Carrico; Jennie Coleman; Alexis M Roth
Journal:  Soc Sci Med       Date:  2021-03-04       Impact factor: 4.634

4.  Exploring the mechanisms behind HIV drug resistance in sub-Saharan Africa: conceptual mapping of a complex adaptive system based on multi-disciplinary expert insights.

Authors:  Anneleen Kiekens; Bernadette Dierckx de Casterlé; Giampietro Pellizzer; Idda H Mosha; Fausta Mosha; Tobias F Rinke de Wit; Raphael Z Sangeda; Alessio Surian; Nico Vandaele; Liesbet Vranken; Japhet Killewo; Michael Jordan; Anne-Mieke Vandamme
Journal:  BMC Public Health       Date:  2022-03-07       Impact factor: 3.295

5.  Slow Uptake of PrEP: Behavioral Predictors and the Influence of Price on PrEP Uptake Among MSM with a High Interest in PrEP.

Authors:  Mart van Dijk; John B F de Wit; Thomas E Guadamuz; Joel E Martinez; Kai J Jonas
Journal:  AIDS Behav       Date:  2021-02-21

6.  'We have goals but [it is difficult]'. Barriers to antiretroviral therapy adherence among women using alcohol and other drugs living with HIV in South Africa.

Authors:  Jacqueline W Ndirangu; Margaret W Gichane; Felicia A Browne; Courtney P Bonner; William A Zule; Erin N Cox; Kevin M Smith; Tara Carney; Wendee M Wechsberg
Journal:  Health Expect       Date:  2022-01-21       Impact factor: 3.318

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.